HHLR Advisors, Ltd. 13D and 13G filings for Cytek Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:39 pm Sale |
2023-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
HHLR Advisors, Ltd. | 6,657,030 4.900% |
-2,027,500 (-23.35%) |
Filing |
| 2023-02-14 4:09 pm Sale |
2022-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
HHLR Advisors, Ltd. | 8,684,530 6.400% |
-72,500 (-0.83%) |
Filing |
| 2022-02-14 4:09 pm Purchase |
2021-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
HHLR Advisors, Ltd. | 8,757,030 6.500% |
8,757,030 (New Position) |
Filing |